QNTM - Quantum BioPharma Ltd. Net earnings per share (EPS TTM)

Symbol and logo of brand Quantum BioPharma (QNTM)

Quantum BioPharma Ltd (QNTM) develops orphan disease medications through partnerships with biotech laboratories. Rolling trailing twelve-month net income per share demonstrates current financial stability, and this metric has reached the level of -5.74. Revenues are based on royalties from inflammation therapy patents, however, frequent strategic shifts between AI and cannabinoids weaken the company's competitive advantages.

QNTM (Quantum BioPharma Ltd) Net earnings per one share for the last twelve months history from 08/16/2024 to 11/13/2026

Analytical breakdowns for Quantum BioPharma Ltd

- share price and expert price forecast:
Stock Quotes Quantum BioPharma Ltd|QNTM - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Quantum BioPharma Ltd|QNTM - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Quantum BioPharma|QNTM - Total Stockholders' Equity|Market Value to Book Value Ratio quantumbiopharma.com|QNTM - Aggregate Asset Value
- debt obligations and liquidity statistics:
Debt to Equity Quantum BioPharma Ltd|QNTM - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio Quantum BioPharma Limited|QNTM - Company Aggregate Debts|Debts to Book Capitalization Quantum BioPharma Ltd|QNTM - Company Long-Term Debts|Company Short-Term Debt Quantum BioPharma|Quick Liquidity Indicator quantumbiopharma.com
- net income and valuation multiples indicators:
QNTM - Profit After Payment of Taxes|Future Profit Quantum BioPharma Ltd|QNTM - P/E Multiple|Future Price to Earnings Quantum BioPharma|QNTM - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Quantum BioPharma Ltd|QNTM - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Quantum BioPharma|QNTM - Earnings per share for the last twelve months|Quarterly EPS earnings growth quantumbiopharma.com|QNTM - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Quantum BioPharma Ltd
- revenue and sales proceeds data:
QNTM - Company Total Revenue|Company Projected Revenue Quantum BioPharma Ltd|QNTM - Price-to-Sales Ratio
Analysis of all company metrics:Quantum BioPharma Ltd (QNTM)
Mass-produced product of Quantum BioPharma Corp

The operational efficiency of Quantum BioPharma Ltd (QNTM) is reflected in the current annual net earnings per share. This indicator captures the balance between the issuer's production capacity and market demand over a rolling year. The calculated value of -5.74 determines the real return on each share of capital, adjusted for dilution. Amidst saturation in the biotechnology market, this metric assesses the success of diversification into the sleep therapy segment. The stability of this figure confirms the resilience of the company's assets.

Competitors of Quantum BioPharma Ltd (QNTM)

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia LQDA|Net earnings per share for the trailing year Galapagos N.V.|ANIP: Net earnings per share for the last 12 months|MNKD - Net earnings per share (EPS TTM)|AMPH: Net earnings per share (EPS TTM)|pacira.com (PCRX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ARS Pharmaceuticals, Inc.|Earnings per share for the last 12 months TBPH (Theravance Biopharma Inc)|Net earnings per share for the last 12 months AQST (Aquestive Pharma)|Earnings per share for the last four quarters SCPH|Tectonic Therapeutic - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) tonixpharma.com TNXP|SXTC - Earnings per share for the last twelve months|Eupraxia Pharmaceuticals (EPRX) - Net earnings per share for the last 12 months|BHST (BioHarvest) - Net earnings per share for the last 12 months|Invizyne - Earnings per share for the trailing year|ORMP (Oramed) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ENTX|Net earnings per share (EPS TTM) HYFT|Net earnings per share for the last four quarters ABVC BioPharma Inc.|Earnings per share for the last twelve months Cumberland Pharma CPIX|FibroGen Corporation (FGEN) - Net earnings per one share for the last twelve months|TELO - Earnings per share for the last twelve months|Earnings per one share for the last 12 months RANI|SNYR: Net earnings per share (EPS TTM)|Rallybio - Earnings per share for the trailing year|LEXX (Lexaria Bioscience Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Pulmatrix Corporation|Earnings per share for the last twelve months Pheton Holdings Ltd (PTHL)|APM (aptorumgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Lyra Therapeutics LYRA|IBO - Net earnings per share for the last 12 months|TNF Pharma - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX (PainReform Ltd.) - Net earnings per share for the last 12 months|Altamira Therapeutics Ltd. - Earnings per share for the trailing year|Earnings per share for the last twelve months Lipella Pharmaceuticals, Inc.|Earnings per share for the last twelve months OPTN|Net earnings per share for the last 12 months PIRS (Pieris)|Earnings per share for the last four quarters PROC|Net earnings per share (EPS TTM) PTPI (Petros Pharmaceuticals)|QLI: Earnings per share for the last 12 months|SLRN - Earnings per share for the last twelve months|Net earnings per share for the trailing year TFF Pharmaceuticals Inc. (TFFP)